67 related articles for article (PubMed ID: 2699920)
1. Short term treatment of type II hyperlipoproteinaemia with silymarin.
Somogyi A; Ecsedi GG; Blázovics A; Miskolczi K; Gergely P; Fehér J
Acta Med Hung; 1989; 46(4):289-95. PubMed ID: 2699920
[TBL] [Abstract][Full Text] [Related]
2. [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases].
Fehér J; Deák G; Müzes G; Láng I; Niederland V; Nékám K; Kárteszi M
Orv Hetil; 1989 Dec; 130(51):2723-7. PubMed ID: 2574842
[TBL] [Abstract][Full Text] [Related]
3. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
Elgzyri T; Castenfors J; Hägg E; Backman C; Thorén M; Bramnert M
Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
[TBL] [Abstract][Full Text] [Related]
4. Acifran: a double-blind, randomized, placebo-controlled efficacy study in type IIa hyperlipoproteinemic patients.
LaRosa JC; Miller VT; Edwards KD; DeBovis MR; Stoy DB
Artery; 1987; 14(6):338-50. PubMed ID: 3314798
[TBL] [Abstract][Full Text] [Related]
5. [Immunomodulator effect of silymarin therapy in chronic alcoholic liver diseases].
Deák G; Müzes G; Láng I; Niederland V; Nékám K; Gonzalez-Cabello R; Gergely P; Fehér J
Orv Hetil; 1990 Jun; 131(24):1291-2, 1295-6. PubMed ID: 2195425
[TBL] [Abstract][Full Text] [Related]
6. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
7. A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.
Gaspard U; Endrikat J; Desager JP; Buicu C; Gerlinger C; Heithecker R
Contraception; 2004 Apr; 69(4):271-8. PubMed ID: 15033400
[TBL] [Abstract][Full Text] [Related]
8. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
9. Effect of citrus flavonoids and tocotrienols on serum cholesterol levels in hypercholesterolemic subjects.
Roza JM; Xian-Liu Z; Guthrie N
Altern Ther Health Med; 2007; 13(6):44-8. PubMed ID: 17985810
[TBL] [Abstract][Full Text] [Related]
10. Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation.
Tietge UJ; Boker KH; Bahr MJ; Weinberg S; Pichlmayr R; Schmidt HH; Manns MP
Hepatogastroenterology; 1998; 45(24):2255-60. PubMed ID: 9951906
[TBL] [Abstract][Full Text] [Related]
11. [Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol)].
Müzes G; Deák G; Láng I; Nékám K; Niederland V; Fehér J
Orv Hetil; 1990 Apr; 131(16):863-6. PubMed ID: 2345633
[TBL] [Abstract][Full Text] [Related]
12. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
[TBL] [Abstract][Full Text] [Related]
13. Short-term effects of renal transplantation on plasma lipids and lipoprotein lipase in children with congenital nephrosis.
Antikainen M; Holmberg C; Taskinen MR
Clin Nephrol; 1994 May; 41(5):284-9. PubMed ID: 8050208
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men.
Anderson JW; Zettwoch N; Feldman T; Tietyen-Clark J; Oeltgen P; Bishop CW
Arch Intern Med; 1988 Feb; 148(2):292-6. PubMed ID: 3277558
[TBL] [Abstract][Full Text] [Related]
15. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ
Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612
[TBL] [Abstract][Full Text] [Related]
16. Testosterone enanthate at a dose of 200 mg/week decreases HDL-cholesterol levels in healthy men.
Meriggiola MC; Marcovina S; Paulsen CA; Bremner WJ
Int J Androl; 1995 Oct; 18(5):237-42. PubMed ID: 8567093
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of micronised fenofibrate in a randomised double-blind study comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia.
Krempf M; Rohmer V; Farnier M; Issa-Sayegh M; Corda C; Sirugue I; Gerlinger C; Masseyeff-Elbaz MF
Diabetes Metab; 2000 May; 26(3):184-91. PubMed ID: 10880891
[TBL] [Abstract][Full Text] [Related]
18. Lowering effect of fenofibrate (procetofene) on lipoproteins in different types of hyperlipoproteinemias.
Canzler H; Bojanovski D
Artery; 1980; 8(2):171-8. PubMed ID: 7458684
[TBL] [Abstract][Full Text] [Related]
19. Effects of hazelnut-enriched diet on plasma cholesterol and lipoprotein profiles in hypercholesterolemic adult men.
Mercanligil SM; Arslan P; Alasalvar C; Okut E; Akgül E; Pinar A; Geyik PO; Tokgözoğlu L; Shahidi F
Eur J Clin Nutr; 2007 Feb; 61(2):212-20. PubMed ID: 16969381
[TBL] [Abstract][Full Text] [Related]
20. Influence of cholesterol-lowering on plasma membrane lipids and function.
Lijnen P; Echevaría-Vázquez D; Petrov V
Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
